PSORIASIS

Psoriasis is a frequent multifactorial chronic inflammatory skin disease affecting approximately 2-3 % of the population. Th-17 and Th-22 T-cell subsets play a major role in the establishment of psoriasis. Th-17 lymphocytes are highly activated in psoriatic skin, releasing inflammatory cytokines involved in psoriasis plaques. Additionally, Th-22 secreted cytokines activate the proliferation and differentiation of keratinocytes, resulting in the specific hyperplasia of psoriatic epidermis.

mRNA expression in RHE-Th17

In response to the need for evaluating beneficial compounds to cure psoriasis, StratiCELL has set up 2D keratinocytes and 3D reconstructed epidermis stimulated by Th-17 or Th-22 like cytokines, to replicate psoriasis features of inflammation and hyperplasia. Those in vitro models are highly adapted to evaluate beneficial dermo-cosmetic actives to cure psoriasis.

Download our Psoriasis brochure

Feel free to download our brochure to have more informations.